NES
BIIB icon

New England Securities’s Biogen BIIB Stock Holding History

New England Securities’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$35K Sell
103
-476
-82% -$154K 0.01% 686
2014
Q3 		$192K Buy
579
+555
+2,313% +$183K 0.07% 289
2014
Q2 		$8K Sell
24
-240
-91% -$72.2K ﹤0.01% 1160
2014
Q1 		$81K Buy
264
+250
+1,786% +$79.4K 0.03% 435
2013
Q4 		$4K Sell
14
-18
-56% -$4.66K ﹤0.01% 1260
2013
Q3 		$8K Hold
32
– – ﹤0.01% 1041
2013
Q2 		$7K Buy
+32
New +$6.84K ﹤0.01% 957

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

New England Securities's BIIB Position: Q4 2014 in Review

New England Securities reduced its Biogen (BIIB) stake by 82% in Q4 2014, selling an estimated $154K and leaving 103 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #686.

New England Securities first reported a position in BIIB in Q2 2013 and has held it in 7 quarters since. The position peaked at $192K in Q3 2014. 884 funds tracked by Wall St. Rank hold BIIB as of Q4 2014.

  • New England Securities held 103 shares of Biogen worth $35K as of Q4 2014.
  • New England Securities sold 476 Biogen shares in Q4 2014, an estimated $154K.
  • Biogen made up 0.01% of New England Securities's portfolio in Q4 2014, its #686 holding.
  • New England Securities first reported a position in Biogen in Q2 2013 and has held it in 7 quarters since.
  • New England Securities's Biogen position peaked at $192K in Q3 2014.
  • 884 funds tracked by Wall St. Rank held Biogen as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.